Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CORR
2901
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $1.79M | ﹤0.01% |
196,292
+7,093
| +4% | +$89.3K |
|
2902
Evolus
EOLS
$398M
| $1.79M | ﹤0.01% |
338,574
+6,411
| +2% | +$29.5K |
|
2903
PCB Bancorp
PCB
$394M
| $1.78M | ﹤0.01% |
172,963
+4,896
| +3% | +$44.4K |
|
|
CVLY
2904
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $1.78M | ﹤0.01% |
128,562
+4,366
| +4% | +$58.2K |
|
2905
Lands' End
LE
$382M
| $1.77M | ﹤0.01% |
220,243
+7,262
| +3% | +$52.2K |
|
|
SI
2906
DELISTED
Silvergate Capital Corporation
SI
| $1.76M | ﹤0.01% |
125,888
+75,032
| +148% | +$1.01M |
|
2907
Pixelworks
PXLW
$39.3M
| $1.76M | ﹤0.01% |
45,382
+19,906
| +78% | +$861K |
|
|
SCWX
2908
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $1.76M | ﹤0.01% |
153,724
+8,450
| +6% | +$100K |
|
2909
Dr. Reddy's Laboratories
RDY
$10.1B
| $1.75M | ﹤0.01% |
167,280
+103,020
| +160% | +$1.05M |
|
2910
Wrap Technologies
WRAP
$106M
| $1.75M | ﹤0.01% |
167,088
+19,039
| +13% | +$114K |
|
2911
Rockwell Medical
RMTI
$28.5M
| $1.75M | ﹤0.01% |
8,156
+65
| +0.8% | +$15.4K |
|
2912
Unity Bancorp
UNTY
$594M
| $1.74M | ﹤0.01% |
121,686
+3,961
| +3% | +$54.2K |
|
2913
Shore Bancshares
SHBI
$820M
| $1.74M | ﹤0.01% |
156,498
+4,276
| +3% | +$41.9K |
|
2914
First Business Financial Services
FBIZ
$604M
| $1.72M | ﹤0.01% |
104,334
+7,868
| +8% | +$123K |
|
2915
Coastal Financial
CCB
$651M
| $1.72M | ﹤0.01% |
118,136
+14,428
| +14% | +$190K |
|
2916
BeyondSpring
BYSI
$48.1M
| $1.71M | ﹤0.01% |
113,531
+19,810
| +21% | +$302K |
|
|
IVAC
2917
DELISTED
Intevac Inc
IVAC
| $1.71M | ﹤0.01% |
313,656
+152,200
| +94% | +$792K |
|
|
MBCN
2918
DELISTED
Middlefield Banc Corp
MBCN
| $1.71M | ﹤0.01% |
82,433
+38,442
| +87% | +$713K |
|
2919
Harrow
HROW
$1.46B
| $1.71M | ﹤0.01% |
328,130
+141,840
| +76% | +$697K |
|
|
SREV
2920
DELISTED
ServiceSource International, Inc.
SREV
| $1.71M | ﹤0.01% |
1,079,962
+552,211
| +105% | +$754K |
|
|
FNHC
2921
DELISTED
FedNat Holding Company Common Stock
FNHC
| $1.71M | ﹤0.01% |
154,079
+5,701
| +4% | +$66.5K |
|
|
NARI
2922
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $1.7M | ﹤0.01% |
+35,178
| New | +$1.68M |
|
|
JNCE
2923
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.7M | ﹤0.01% |
246,144
-1,384
| -0.6% | -$7.46K |
|
2924
Celldex Therapeutics
CLDX
$2.96B
| $1.69M | ﹤0.01% |
130,237
+26,254
| +25% | +$116K |
|
2925
UBS Group
UBS
$173B
| $1.69M | ﹤0.01% |
146,554
-183,366
| -56% | -$1.89M |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.